SCHEMBL5094880

SCHEMBL5094880

c1cc2cn[nH]c2cc1N1CCN2CCCC2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.45
PDGFRB P09619 2/20 0.43
PDGFRA P16234 2/20 0.43
HRH3 Q9Y5N1 3/20 0.43
ADCY5 O95622 1/20 0.43
SYK P43405 1/20 0.42
HRH4 Q9H3N8 2/20 0.41
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
APAF1 O14727 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
MAPK1 P28482 1/20 0.40
BLM P54132 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
PARP1 P09874 1/20 0.40
TNK2 Q07912 1/20 0.40
TNK1 Q13470 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4555174 0.81 HTR6 (0.47) HTR6HRH3ADCY5SYKHRH4
SCHEMBL30837522 0.79 NOS1 (0.52) PDGFRBPDGFRASYKKDM4EMEN1
SCHEMBL5103438 0.77 HTR6 (0.50) HTR6HRH3ADCY5SYKKDM4E
SCHEMBL18399080 0.76 ABL1 (0.48) SYKKDM4EMEN1APAF1ALDH1A1
SCHEMBL29039315 0.76 NOS1 (0.49) PDGFRBPDGFRASYKKDM4EMEN1
SCHEMBL30385421 0.76 NOS1 (0.49) PDGFRBPDGFRASYKKDM4EMEN1
SCHEMBL3190345 0.76 MAPT (0.49) SYKKDM4EMEN1APAF1ALDH1A1
SCHEMBL30469212 0.75 TERT (0.53) PDGFRBPDGFRASYKKDM4EMEN1
SCHEMBL5095062 0.73 FGFR1 (0.56) PDGFRBPDGFRAKDM4EMEN1ALDH1A1
SCHEMBL22073939 0.72 HDAC4 (0.47) HTR6HRH3ADCY5HDAC4MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
WO-2008101247-A2 6 ' SUBSTITUTED INDOLE AND INDAZOLE DERIVATIVES HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR1B, HTR1A HTR6 1/4885PDGFRB 230/4885PDGFRA 278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.